Market revenue in 2023 | USD 18.3 million |
Market revenue in 2030 | USD 29.0 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Copolymer pom |
Fastest growing segment | Copolymer POM |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Homopolymer POM, Copolymer POM |
Key market players worldwide | Dow Inc, Celanese Corp Class A, DuPont de Nemours Inc, Daicel Corp, Asahi Kasei Corp, Mitsubishi Gas Chemical Co Inc, SABIC, Avient Corp, Clariant AG, Jet-Hot, Innovative Plastics, Korea Engineering Plastics Co., China National Bluestar Group, ICD High Performance Coatings |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical polyoxymethylene (pom) market will help companies and investors design strategic landscapes.
Copolymer pom was the largest segment with a revenue share of 62.84% in 2023. Horizon Databook has segmented the U.S. medical polyoxymethylene (pom) market based on homopolymer pom, copolymer pom covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. plays a major role in the medical POM market, with several factors contributing to its significance. The well-developed infrastructure and the presence of renowned medical device manufacturers propel the development of the medical industry in the U.S., creating significant application scope for the market in this country.
According to the American Medical Association, the country's high healthcare expenditure amounted to USD 13, 493 per capita in 2023. This underscores its crucial role in driving the medical POM market. Additionally, medical device manufacturers in the U.S. are incorporating recycled POM into their products to reduce their environmental impact, which is likely to propel the market in the country.
The insulin pen has dominated the product segment in the medical POM market in the U.S. This dominance reflects the increasing demand for insulin pens as an effective diabetes care and treatment option, driven by the rise in the number of diabetes patients.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. medical polyoxymethylene (pom) market , including forecasts for subscribers. This country databook contains high-level insights into U.S. medical polyoxymethylene (pom) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account